Imaging in the era of molecular oncology
R Weissleder, MJ Pittet - Nature, 2008 - nature.com
New technologies for imaging molecules, particularly optical technologies, are increasingly
being used to understand the complexity, diversity and in vivo behaviour of cancers.'Omic' …
being used to understand the complexity, diversity and in vivo behaviour of cancers.'Omic' …
In vivo fluorescence spectroscopy and imaging for oncological applications
GA Wagnieres, WM Star… - Photochemistry and …, 1998 - search.proquest.com
Abbreviations: ACF, aberrant crypt foci; ALA, 5-aminolevulinic acid; AIS4PC, tetrasulfonated
chloroaluminum phthalocyanine; antiCEA MoAb, anticarcinoembryonic antigen; BBC, basal …
chloroaluminum phthalocyanine; antiCEA MoAb, anticarcinoembryonic antigen; BBC, basal …
89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies
I Verel, GWM Visser, R Boellaard… - Journal of nuclear …, 2003 - Soc Nuclear Med
The use of immuno-PET, the combination of PET with monoclonal antibodies (mAbs), is an
attractive option to improve tumor detection and mAb quantification. The long-lived positron …
attractive option to improve tumor detection and mAb quantification. The long-lived positron …
Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents
EM Sevick-Muraca, JP Houston, M Gurfinkel - Current opinion in chemical …, 2002 - Elsevier
The deep tissue propagation of near-infrared (NIR) light between 700–900 nm offers new
opportunities for diagnostic imaging when employing sensitive detection techniques and …
opportunities for diagnostic imaging when employing sensitive detection techniques and …
Photosensitizer-antibody conjugates for detection and therapy of cancer
G Van Dongen, GWM Visser… - Advanced drug delivery …, 2004 - Elsevier
Photodynamic therapy (PDT) is a promising approach for the treatment of superficially
localized tumors. A limitation, however, is the lack of selectivity of the photosensitizers, which …
localized tumors. A limitation, however, is the lack of selectivity of the photosensitizers, which …
Fluorescence optical diffusion tomography
A nonlinear, Bayesian optimization scheme is presented for reconstructing fluorescent yield
and lifetime, the absorption coefficient, and the diffusion coefficient in turbid media, such as …
and lifetime, the absorption coefficient, and the diffusion coefficient in turbid media, such as …
Small animal imaging: current technology and perspectives for oncological imaging
Advances in the biomedical sciences have been accelerated by the introduction of many
new imaging technologies in recent years. With animal models widely used in the basic and …
new imaging technologies in recent years. With animal models widely used in the basic and …
Antibody-based imaging strategies for cancer
Although mainly developed for preclinical research and therapeutic use, antibodies have
high antigen specificity, which can be used as a courier to selectively deliver a diagnostic …
high antigen specificity, which can be used as a courier to selectively deliver a diagnostic …
mTHPC–A drug on its way from second to third generation photosensitizer?
MO Senge - Photodiagnosis and Photodynamic Therapy, 2012 - Elsevier
5, 10, 15, 20-Tetrakis (3-hydroxyphenyl) chlorin (mTHPC, Temoporfin) is a widely
investigated second generation photosensitizer. Its initial use in solution form (Foscan®) is …
investigated second generation photosensitizer. Its initial use in solution form (Foscan®) is …
[HTML][HTML] SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery
M Gutowski, B Framery, MC Boonstra, V Garambois… - Surgical oncology, 2017 - Elsevier
Purpose Fluorescence-guided surgery (FGS) provides surgeons with new opportunities to
improve real-time cancer nodule detection and tumor margin visualization. Currently, the …
improve real-time cancer nodule detection and tumor margin visualization. Currently, the …